Vaccitech (VACC) News Today → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free VACC Stock Alerts $5.00 +0.51 (+11.36%) (As of 11/6/2023) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5, 2024 | marketbeat.comVaccitech (NASDAQ:VACC) Trading Down 5.5%Vaccitech (NASDAQ:VACC) Stock Price Down 5.5%May 22, 2024 | markets.businessinsider.comBarinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024May 17, 2024 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics Backed by Strong Financials and Promising Clinical TrialsApril 30, 2024 | msn.comWhat is AstraZeneca Vaccine? Know the Recently Discovered Side Effects of the COVID-19 AntibodyApril 19, 2024 | markets.businessinsider.comBuy Rating on Barinthus Biotherapeutics Backed by Promising Clinical Trials and Strong Valuation ProspectsApril 6, 2024 | msn.comLondon is a bad place to raise money, says life sciences tsar Sir John BellMarch 2, 2024 | seekingalpha.comArbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call TranscriptJanuary 8, 2024 | markets.businessinsider.comPositive Clinical Outlook and Strong Capital Position Justify Buy Rating for Barinthus BiotherapeuticsJanuary 8, 2024 | finanznachrichten.deBarinthus Biotherapeutics: Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesJanuary 5, 2024 | finance.yahoo.comBarinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesDecember 22, 2023 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics: Promising Pipeline and Strategic Partnerships Signal Investment OpportunityDecember 21, 2023 | markets.businessinsider.comBarinthus Biotherapeutics Collaborates With CEPI And University Of Oxford For New MERS VaccineDecember 21, 2023 | finance.yahoo.comNew partnership aims to advance vaccine against MERS coronavirusDecember 13, 2023 | finance.yahoo.comInfluenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - TechnavioNovember 28, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Barinthus Biotherapeutics (BRNS), Anavex Life Sciences (AVXL)November 15, 2023 | finance.yahoo.comBarinthus Biotherapeutics plc (BRNS)November 9, 2023 | finance.yahoo.comBarinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate DevelopmentsNovember 8, 2023 | money.usnews.comBarinthus Biotherapeutics Plc. - ADRNovember 7, 2023 | msn.comBarinthus stock falls 18%, day after changing name from VaccitechNovember 6, 2023 | msn.comVaccitech rebrands as Barinthus, plans to present data at AASLD meetingNovember 6, 2023 | finance.yahoo.comVaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and CancerSeptember 28, 2023 | seekingalpha.comSIRI, EC and PBTS among pre-market losersSeptember 26, 2023 | 247wallst.comMorgan Stanley Downgrades VaccitechSeptember 26, 2023 | uk.finance.yahoo.comInnovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028September 26, 2023 | seekingalpha.comVaccitech surges despite Morgan Stanley downgradeSeptember 26, 2023 | finance.yahoo.comVaccitech plc (NASDAQ:VACC) surges 85%; individual investors who own 44% shares profited along with institutionsSeptember 25, 2023 | benzinga.comGlobal Cancer Vaccines Market to Skyrocket, Projected to Reach $12.1 Billion by 2028September 25, 2023 | marketwatch.comHealth Care Up on Defensive Bets -- Health Care RoundupSeptember 25, 2023 | msn.comMorgan Stanley Downgrades Vaccitech plc - ADR (VACC)September 25, 2023 | marketwatch.comVaccitech Shares Surge as Alliance Global Initiates CoverageSeptember 25, 2023 | marketbeat.comTrading was temporarily halted for "VACC" at 12:09 PM with a stated reason of "LULD pause."September 13, 2023 | finance.yahoo.comVaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023September 12, 2023 | bizjournals.comArbutus BioPharma narrows research focus to extend cash runwayAugust 10, 2023 | finanznachrichten.deVaccitech plc: Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 10, 2023 | finance.yahoo.comVaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 9, 2023 | finance.yahoo.comVaccitech (NASDAQ:VACC) shareholders have endured a 50% loss from investing in the stock a year agoJune 22, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vaccitech Plc (VACC) and Aeglea Biotherapeutics (AGLE)June 13, 2023 | markets.businessinsider.comAnalyst Expectations for Vaccitech's FutureJune 12, 2023 | finance.yahoo.comVaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local TherapyMay 19, 2023 | finance.yahoo.comNewsflash: Vaccitech plc (NASDAQ:VACC) Analysts Have Been Trimming Their Revenue ForecastsMay 17, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Arcus Biosciences (RCUS), Vaccitech Plc (VACC)May 16, 2023 | msn.comMorgan Stanley Maintains Vaccitech plc - ADR (VACC) Overweight RecommendationMay 12, 2023 | msn.comVaccitech: Q1 Earnings InsightsMay 12, 2023 | finance.yahoo.comVaccitech Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 5, 2023 | finance.yahoo.comRevenues Working Against Vaccitech plc's (NASDAQ:VACC) Share PriceApril 17, 2023 | finance.yahoo.comVaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity ProfileMarch 30, 2023 | marketwatch.comGlobal Influenza Vaccines Market Size 2023 to 2026 Size and Share Survey ReportMarch 29, 2023 | markets.businessinsider.comVaccitech Plc (VACC) Gets a Buy from Morgan StanleyMarch 29, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Kodiak Sciences (KOD) and Vaccitech Plc (VACC)March 28, 2023 | finanznachrichten.deVaccitech plc: Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address AI's Next Magnificent Seven (Ad)The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years. See His Breakdown of the Seven Stocks You Should Own Here. VACC Media Mentions By Week VACC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VACC News Sentiment▼0.000.77▲Average Medical News Sentiment VACC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VACC Articles This Week▼10▲VACC Articles Average Week Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CorMedix News Today Nature's Sunshine Products News Today XOMA News Today ADC Therapeutics News Today MacroGenics News Today Mersana Therapeutics News Today Aquestive Therapeutics News Today Immutep News Today Enanta Pharmaceuticals News Today Atai Life Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VACC) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored